We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights Applied Materials, GE, AstraZeneca, Team and Applied Energetics
Read MoreHide Full Article
For Immediate Release
Chicago, IL – June 17, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Applied Materials, Inc. (AMAT - Free Report) , GE Aerospace (GE - Free Report) , AstraZeneca PLC (AZN - Free Report) , Team, Inc. (TISI - Free Report) and Applied Energetics, Inc. (AERG - Free Report) .
Here are highlights from Tuesday’s Analyst Blog:
Top Stock Picks for Applied Materials, GE & AstraZeneca
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Applied Materials, Inc., GE Aerospace and AstraZeneca PLC, as well as two micro-cap stocks, Team, Inc. and Applied Energetics, Inc. These research reports have been hand-picked from roughly 70 reports published by our analyst team today.
Applied Materials’ shares have outperformed the Zacks Electronics - Semiconductors industry over the past year (+236.5% vs. +100.4%). Per the Zacks analyst, the company is benefiting from AI-driven demand that is boosting spending on advanced semiconductor manufacturing and packaging technologies, where it holds strong market positions. New product innovations, deeper customer collaborations, and growing services adoption support pricing power and operational efficiency.
Yet, risks include significant exposure to China amid evolving export restrictions, the cyclical nature of semiconductor capital spending, and intense competition across equipment categories. These factors could create demand volatility and pressure market share.
GE’s shares have outperformed the Aerospace - Defense industry over the past six months (+17.1% vs. -3.6%). The Zacks analyst believes that GE is benefiting from strong demand for commercial engines and advanced aerospace technologies, supported by healthy air travel trends and rising global defense spending. Portfolio optimization efforts also support long-term growth.
Risks include elevated project and restructuring costs, supply-chain disruptions that may increase expenses and delays, and foreign-exchange headwinds from its global operations.
AstraZeneca’s shares have outperformed the Zacks Medical – Biomedical and Genetics industry over the past year (+24.9% vs. +15.0%). The Zacks analyst believes that the company is benefiting from strong demand for key medicines, a robust late-stage pipeline, and strategic acquisitions and collaborations that strengthen future growth. Investments in high-growth emerging markets and new product launches also support its long-term outlook.
However, looming patent expirations for several blockbuster drugs leads to increasing generic competition. Existing generic erosion is already affecting some products, while exclusivity losses for key medicines may pressure future sales growth.
Team’s shares have outperformed the Zacks Building Products – Maintenance Service industry over the past two years (+115.0% vs. -4.0%). The Zacks analyst believes that the company is benefiting from steady demand for infrastructure maintenance and inspection services, supported by its integrated business model, improving operational execution, and margin-enhancing cost and pricing initiatives. Growth opportunities in key markets and renewed strategic focus also support its outlook.
Yet, challenges include a highly leveraged balance sheet, elevated financing costs, and cash flow pressure that limit financial flexibility. Ongoing losses, uneven profitability, capital dilution, and exposure to legal and non-core expenses remain additional headwinds.
Applied Energetics’ shares have underperformed the Zacks Laser Systems and Components industry over the past year (-27.1% vs. +69.2%). The Zacks analyst believes that the company faces pressure from rising costs, persistent losses, cash burn, and dependence on volatile government-funded contracts. Additional risks include dilution, limited trading liquidity, supply-chain constraints, inflationary pressures, and potential project delays.
However, the company continues to advance specialized technologies and development programs, which could support future contract opportunities and long-term growth if execution improves and funding visibility strengthens.
Free: Instant Access to Zacks' Market-Crushing Strategies
Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.
Today you can tap into those powerful strategies – and the high-potential stocks they uncover – free. No strings attached.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
View the Zacks #1 Rank List
Image: Bigstock
The Zacks Analyst Blog Highlights Applied Materials, GE, AstraZeneca, Team and Applied Energetics
For Immediate Release
Chicago, IL – June 17, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Applied Materials, Inc. (AMAT - Free Report) , GE Aerospace (GE - Free Report) , AstraZeneca PLC (AZN - Free Report) , Team, Inc. (TISI - Free Report) and Applied Energetics, Inc. (AERG - Free Report) .
Here are highlights from Tuesday’s Analyst Blog:
Top Stock Picks for Applied Materials, GE & AstraZeneca
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Applied Materials, Inc., GE Aerospace and AstraZeneca PLC, as well as two micro-cap stocks, Team, Inc. and Applied Energetics, Inc. These research reports have been hand-picked from roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Today's Featured Research Reports
Applied Materials’ shares have outperformed the Zacks Electronics - Semiconductors industry over the past year (+236.5% vs. +100.4%). Per the Zacks analyst, the company is benefiting from AI-driven demand that is boosting spending on advanced semiconductor manufacturing and packaging technologies, where it holds strong market positions. New product innovations, deeper customer collaborations, and growing services adoption support pricing power and operational efficiency.
Yet, risks include significant exposure to China amid evolving export restrictions, the cyclical nature of semiconductor capital spending, and intense competition across equipment categories. These factors could create demand volatility and pressure market share.
(You can read the full research report on Applied Materials here >>>)
GE’s shares have outperformed the Aerospace - Defense industry over the past six months (+17.1% vs. -3.6%). The Zacks analyst believes that GE is benefiting from strong demand for commercial engines and advanced aerospace technologies, supported by healthy air travel trends and rising global defense spending. Portfolio optimization efforts also support long-term growth.
Risks include elevated project and restructuring costs, supply-chain disruptions that may increase expenses and delays, and foreign-exchange headwinds from its global operations.
(You can read the full research report on GE here >>>)
AstraZeneca’s shares have outperformed the Zacks Medical – Biomedical and Genetics industry over the past year (+24.9% vs. +15.0%). The Zacks analyst believes that the company is benefiting from strong demand for key medicines, a robust late-stage pipeline, and strategic acquisitions and collaborations that strengthen future growth. Investments in high-growth emerging markets and new product launches also support its long-term outlook.
However, looming patent expirations for several blockbuster drugs leads to increasing generic competition. Existing generic erosion is already affecting some products, while exclusivity losses for key medicines may pressure future sales growth.
(You can read the full research report on AstraZeneca here >>>)
Team’s shares have outperformed the Zacks Building Products – Maintenance Service industry over the past two years (+115.0% vs. -4.0%). The Zacks analyst believes that the company is benefiting from steady demand for infrastructure maintenance and inspection services, supported by its integrated business model, improving operational execution, and margin-enhancing cost and pricing initiatives. Growth opportunities in key markets and renewed strategic focus also support its outlook.
Yet, challenges include a highly leveraged balance sheet, elevated financing costs, and cash flow pressure that limit financial flexibility. Ongoing losses, uneven profitability, capital dilution, and exposure to legal and non-core expenses remain additional headwinds.
(You can read the full research report on Team here >>>)
Applied Energetics’ shares have underperformed the Zacks Laser Systems and Components industry over the past year (-27.1% vs. +69.2%). The Zacks analyst believes that the company faces pressure from rising costs, persistent losses, cash burn, and dependence on volatile government-funded contracts. Additional risks include dilution, limited trading liquidity, supply-chain constraints, inflationary pressures, and potential project delays.
However, the company continues to advance specialized technologies and development programs, which could support future contract opportunities and long-term growth if execution improves and funding visibility strengthens.
(You can read the full research report on Applied Energetics here >>>)
Free: Instant Access to Zacks' Market-Crushing Strategies
Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.
Today you can tap into those powerful strategies – and the high-potential stocks they uncover – free. No strings attached.
Get all the details here >>
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.